Vaginal infections in pregnant patients of a high complexity clinic from Medellín-Colombia

Infecciones vaginales en pacientes gestantes de una clínica de alta complejidad de Medellín-Colombia

Published 2016-06-30


https://doi.org/10.30554/archmed.16.1.790.2016
Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 16 No. 1
Section
Research Articles
How to Cite
Rojas Jimenez, S., Lopera Valle, J. S., Rodríguez Padilla, L. M., & Martínez Sánchez, L. M. (2016). Vaginal infections in pregnant patients of a high complexity clinic from Medellín-Colombia. Archivos De Medicina (Manizales), 16(1), 32-42. https://doi.org/10.30554/archmed.16.1.790.2016
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.16.1.790.2016
Dimensions
PlumX

How to Cite

Rojas Jimenez, S., Lopera Valle, J. S., Rodríguez Padilla, L. M., & Martínez Sánchez, L. M. (2016). Vaginal infections in pregnant patients of a high complexity clinic from Medellín-Colombia. Archivos De Medicina (Manizales), 16(1), 32-42. https://doi.org/10.30554/archmed.16.1.790.2016

Download Citation

license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Sara Rojas Jimenez
Johan Sebastián Lopera Valle
Libia María Rodríguez Padilla
Lina Maria Martínez Sánchez
Perfil Google Scholar
Show authors biography

Most read articles by the same author(s)

1 > >> 

Objective: to describe the characteristics of vaginal infections in pregnant patients. pregnancy is a predisposing factor for vaginal infections, which can lead to deleterious consequences for mother and fetus. Materials and methods: a cross-sectional study. Population consists in pregnant patients diagnosed with vaginal infection in a high complexity clinic, January 2011 to June 2012. Sociodemographic, clinical, microbiological and therapeutic information were collected from the clinical histories of the patients. Results: 67 patients were included, with a median age of 23 (IQR 21-29) years; 40% were in their first pregnancy and 66% were nulliparous. Only 15% of vaginal infections occurred in the first trimester of pregnancy. The most frequently reported symptoms were vaginal discharge (59.7 %), lower urinary tract symptoms (26.9 %) and vulvar pruritus (23.9 %); the main physical findings were vaginal discharge (79.1 %) and vaginal stench (16.4 %). In 67.2% of cases were ordered the direct and gram of vaginal discharge, of which 64.4% were performed during hospitalization. Leukocyte reaction was present in all patients and in 90 % was moderate to abundant. 8 out of 10 patients had blastoconidia and pseudomycelia. The most common microbiological diagnose was vulvovaginal candidiasis (41.4 %), followed by bacterial vaginosis (24.1 %). Conclusion: vaginal infections are a condition with frequent symptoms, which usually occurs in the second half of pregnancy, being the Candida spp. the most common etiology.

Article visits | PDF visits

Downloads

Download data is not yet available.
  1. Zettelman HJ. Infecciones vaginales comunes. Ginecol Obstet Mex 2007;75:115-8.
  2. Perea EJ. Infecciones del aparato genital femenino: vaginitis, vaginosis y cervicitis. Medicine. 2010;10(57):3910-4.
  3. Milhet N, de Dios JA, Pérez EE, Milhet A. Calidad en la aplicación de la estrategia contra el síndrome del flujo vaginal en gestantes. MEDISAN. 2011;15(6):789-97.
  4. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006;58(2):266-72.
  5. Spence D, Mellville C. Vaginal discharge. BMJ. 2007; 335:1147-51.
  6. Miranda A, Hernández LL, Romero C. Infección vaginal en gestantes y su incidencia en indicadores seleccionados del Programa Materno Infantil. Rev Cubana Med Gen Integr. 2010;26(2)291-300.
  7. Sánchez-Hernández JA, Castellanos-Vázquez S, Rivera-Tapia JA. Leucorrea como signo de infecciones cérvicovaginales. Rev Costarr Salud Pública. 2013;22:56-60.
  8. Pimentel B, Reynolds E. Candidiasis vaginal. Rev Paceña Med Fam. 2007;4(6):121-7.
  9. Lima TM, Teles LM, de Oliveira AS, Campos FC, Barbosa Rde C, Pinheiro AK, et al. [Vaginal discharge in pregnant women: comparison between syndromic approach and examination of clinical nursing practice]. Rev Esc Enferm USP. 2013;47(6):1265-71.
  10. Coppolillo EF, Vay C, Menghi C, Cora M, Gatta C, Méndez, et al. Prevalencia de infecciones vaginales en embarazadas sintomáticas y asintomáticas. Rev Enfer Tract Gen Inf. 2007;1(1):17-22
  11. Braun H, Vera C, Belma C, Carvajal JA. Consecuencias perinatales de la infección intrauterina por cándida. Rev Chil Obstet Ginecol 2003; 68(4): 343-8.
  12. da Fonseca TM, Cesar JA, Mendoza-Sassi RA, Schmidt EB. Pathological Vaginal Discharge among Pregnant Women: Pattern of Occurrence and Association in a Population-Based Survey. Obstet Gynecol Int. 2013;2013:590416.
  13. Cesar JA, Mendoza-Sassi RA, González-Chica DA, Menezes EH, Brink G, Pohlmann M, et al. Prevalence of self-reported vaginal discharge and associated factors in pregnant women. Cad Saude Publica. 2009;25(12):2705-14.
  14. Larsson PG, Fåhraeus L, Carlsson B, Jakobsson T, Forsum U. Predisposing factors for bacterial vaginosis, treatment efficacy and pregnancy outcome among term deliveries; results from a preterm delivery study. BMC Womens Health. 2007;7:20.
  15. Alves D, Cassamassimo M, Guimarães M, Garcia C. Alteración de la flora vaginal en gestantes de bajo riesgo atendidas en servicio público de salud: prevalencia y asociación a la sintomatología y hallazgos del examen ginecológico. Rev. Latino-Am. Enfermagem. 2010;18(5):1-9.
  16. Torres P, Meneses AL, Sandoval P, Gaona E, Rivera D, Bejarano A, et al. Estudio de serie de casos: factores de riesgo de flujos vaginales patológicos en gestantes. Rev. colomb. Enferm. 2009;4(4):31-8.
  17. Montes E, Payan M, Pérez M, Loyola M. Comportamiento clínico epidemiológico de la infección vaginal en gestantes de dos consultorios. AMC. 2005;9(3):1-9.
  18. Ibrahim SM, Bukar M, Mohammed Y, Audu BM, Ibrahim HM. Prevalence of vaginal candidiasis among pregnant women with abnormal vaginal discharge in Maiduguri. Niger J Med. 2013;22(2):138-42.
  19. Ibrahim SM, Bukar M, Galadima GB, Audu BM, Ibrahim HA. Prevalence of bacterial vaginosis in pregnant women in Maiduguri, North-Eastern Nigeria. Niger J Clin Pract. 2014;17(2):154-8.
  20. Mendoza A, Sánchez J. Frecuencia de vaginosis producida por Gardnerella vaginalis y su asociación con otros patógenos causantes de infección vaginal en la mujer. Ginecol Obstret Mex. 2006;69(7):272-6.
  21. Cohen CR, Plomer FA, Mugo N, Maclean I, Shen C, Bukusi EA, et al. VIH and others sexually diseses in university Washington seatle. AIDS. 2007;3(5):322-42.
  22. Amsel R. Nonspecific vaginitis: diagnostic criteria and microbiologic and epidemiologic associations. Am J Med. 2005;74:14-22.
  23. Fonseca TMV, César JA, Hackenhaar AA, Ulmi EE, Neumann NA. Corrimento vaginal referido entre gestantes em localidade urbana no sul do Brasil: prevalência e fatores associados. Cad Saúde
  24. Pública. 2008;24(3):558-66.
  25. Salas N, Ramírez JF, Ruiz B, Torres E, Jaramillo LN, Gómez-Marín, et al. Prevalencia de microorganismos asociados a infecciones vaginales en 230 mujeres gestantes y no gestantes sintomáticas del Centro de Salud La Milagrosa en el municipio de Armenia (Colombia). Rev Colomb Obstet Ginecol. 2009; 60(2): 135-142.
  26. Shimano S, Nishikawa A, Sonoda T, Kudo R. Analysis of the prevalence of bacterial vaginosis and Chlamydia trachomatis infection in 6,083 pregnant women at a hospital in Otaru, Japan. J Obstet Gynecol Res 2004; 30: 230-236.
  27. Coppolillo E, Perazzi B, Vay C, Cora Eliseht M, Tauscher P, Barata A y cols. Metodología diagnóstica para las infec ciones del tracto genital inferior durante el embarazo. Ginecol Reprod 2000;7:76-81.
  28. Flores-Paz R, Rivera-Sánchez R, García-Jiménez E, Arriaga-Alba M. Etiología de la infección cérvico vaginal en pacientes del Hospital Juárez de México. Salud Publica Mex 2003;45:S694-7.
  29. Blackwell AL, Thomas PD, Wareham K, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993; 342: 206-210.
  30. Schneider A. Screening for sexually transmitted diseases in rural southem african women. Sex Transm Infect 1998; (Suppl 1):147-52
  31. Gallardo J, Valdés S, Díaz M, Romay C. Comportamiento de las enfermedades de transmisión sexual en pacientes con sepsis ginecológica. Rev Cubana Obstet Ginecol 2000;26(1):10-4.
  32. González Melian. Principales causas de infección vaginal en gestantes ingresadas en el Hospital “Reynaldo Chiang Vargas” durante enero-abril 2001. Rev. Cubana Obstet Ginecol 2002;26(2):74-81.
  33. Medina R, Rechkemmer A, Garcia-Hjarles M. Prevalencia de vaginitis y vaginosis bacteriana en pacientes con flujo vaginal anormal en el Hospital Nacional Arzobispo Loayza. Rev Med Hered 1999; 10:144-50.
  34. Behets FM, Desormeaux J, Joseph D, Adrien M, Coicou G, Dallabetta G, et al. Control of sexually transmitted diseases in Haiti: results and implications of a baseline study among pregnant women living in cite Soleil Shantytowns. J Infect Dis 1995;172:764-71.
  35. Alvis N, Mattar S, Garcia J, Conde E, Diaz A. Sexually transmitted infection in a high-risk group from Montería, Colombia. Rev Salud Publica (Bogota). 2007;9:86-96.
  36. Benito-Vilella FJ, Aguilera-Zubizarreta E, Cuesta Perez-Camino A, Pardo VR, Gomez QB, Rodríguez-Patino E et al. Prevalence of vaginal candidiasis in a low-risk obstetric population in Santander. Aten Primaria 2000; 25: 103-106.
  37. García PJ, Chavez S, Feringa B, Chiappe M, Li W, Jansen KU, et al. Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru. Bull World Health Organ 2004;82:483-92.
  38. Klufio CA, Amoa AB., Delamare O, Hombhanje M, Kariwiga G, Igo J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. PNG Med J 1995; 38: 163-171
  39. Kamara P, Hylton-Kong T, Brothwaite A, Del Rosario GR, Kristensen S, Patrick N y cols. Vaginal infections in pregnant women in Jamaica: prevalence and risk factors. Int J STD AIDS 2000; 11: 516-520.
  40. Cires M, Freijoso E, Silva L, Vergara E, Cutié E, Ortega M, et al. Guía para la práctica clínica de las infecciones vaginales. Rev Cubana Farm 2003;37(1):38-52
  41. Parrado R. Empleo de metronidazol durante el primer trimestre de embarazo: revisión bibliográfica. Rev Colomb Obstet Ginecol. 2003; 54(1): 41-6.
  42. Mølgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013;369:830-9.
  43. Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother. 2008;62(1):172-6.
  44. Vlachadis N, Iliodromiti Z, Vrachnis N. Oral fluconazole during pregnancy and risk of birth defects. N Engl J Med. 2013;369(21):2061.
  45. Sobel JD. Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Prefer Adherence. 2013;8:31-34.

Information

Google Scholar Profile

Author Guidelines